Angiodynamics (ANGO) Return on Invested Capital (2011 - 2025)

Angiodynamics' Return on Invested Capital history runs 15 years deep, the most recent figure standing at 0.04% for Q4 2025.

• Quarterly Return on Invested Capital rose 4.0% year-over-year to 0.04% in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 0.04% (up 4.0% YoY) and the FY2024 annual result came in at 0.19%, down 15.0% from the prior year.
• Return on Invested Capital was 0.04% for Q4 2025 at Angiodynamics, down from 0.03% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q3 2023 and bottomed at 2.01% in Q1 2021.
• A 5-year average of 0.16% and a median of 0.02% in 2022 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2021 — Return on Invested Capital sank 201 bps — and 2025, when it climbed 6 bps.
• Angiodynamics' Return on Invested Capital stood at 2.01% in 2021, then surged by 99 bps to 0.01% in 2022, then jumped by 77 bps to 0.0% in 2023, then slumped by 2710 bps to 0.09% in 2024, then soared by 50 bps to 0.04% in 2025.
• Business Quant data shows ANGO's Return on Invested Capital at 0.04% in Q4 2025, 0.03% in Q3 2025, and 0.02% in Q2 2025.